News Image

Why NASDAQ:PGNY Is a Standout High-Growth Stock in a Consolidation Phase.

By Mill Chart

Last update: Feb 22, 2024

Exploring Growth Potential: PROGYNY INC (NASDAQ:PGNY) and Its Base Formation. Growth investors seek promising revenue and EPS growth, and PROGYNY INC has come under our scrutiny for potential growth investing. While it's crucial to do your own research, we've detected PROGYNY INC on our screen for growth with base formation, suggesting it merits a closer look.

Growth Assessment of NASDAQ:PGNY

ChartMill assigns a Growth Rating to each stock, ranging from 0 to 10. This rating is determined by analyzing different growth elements, including EPS and revenue growth, spanning both historical and future figures. In the case of NASDAQ:PGNY, the assigned 8 reflects its growth potential:

  • The Earnings Per Share has grown by an impressive 23.81% over the past year.
  • Looking at the last year, PGNY shows a very strong growth in Revenue. The Revenue has grown by 47.53%.
  • Measured over the past years, PGNY shows a very strong growth in Revenue. The Revenue has been growing by 74.52% on average per year.
  • Based on estimates for the next years, PGNY will show a very strong growth in Earnings Per Share. The EPS will grow by 45.53% on average per year.
  • The Revenue is expected to grow by 22.58% on average over the next years. This is a very strong growth

Assessing Health for NASDAQ:PGNY

A critical element of ChartMill's stock evaluation is the Health Rating, which spans from 0 to 10. This rating considers multiple health factors, including liquidity and solvency, both in absolute terms and relative to industry peers. NASDAQ:PGNY has received a 8 out of 10:

  • PGNY has an Altman-Z score of 13.47. This indicates that PGNY is financially healthy and has little risk of bankruptcy at the moment.
  • PGNY's Altman-Z score of 13.47 is amongst the best of the industry. PGNY outperforms 97.35% of its industry peers.
  • There is no outstanding debt for PGNY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
  • A Current Ratio of 3.16 indicates that PGNY has no problem at all paying its short term obligations.
  • PGNY's Current ratio of 3.16 is amongst the best of the industry. PGNY outperforms 89.38% of its industry peers.
  • A Quick Ratio of 3.16 indicates that PGNY has no problem at all paying its short term obligations.
  • PGNY's Quick ratio of 3.16 is amongst the best of the industry. PGNY outperforms 89.38% of its industry peers.

Evaluating Profitability: NASDAQ:PGNY

ChartMill employs its own Profitability Rating system for stock evaluation. This score, ranging from 0 to 10, is derived from an analysis of diverse profitability metrics and margins. In the case of NASDAQ:PGNY, the assigned 6 is noteworthy for profitability:

  • Looking at the Return On Assets, with a value of 7.16%, PGNY belongs to the top of the industry, outperforming 86.73% of the companies in the same industry.
  • The Return On Equity of PGNY (10.09%) is better than 74.34% of its industry peers.
  • PGNY's Return On Invested Capital of 7.66% is fine compared to the rest of the industry. PGNY outperforms 79.65% of its industry peers.
  • The 3 year average ROIC (6.26%) for PGNY is below the current ROIC(7.66%), indicating increased profibility in the last year.
  • PGNY has a better Profit Margin (5.03%) than 82.30% of its industry peers.
  • PGNY has a better Operating Margin (5.00%) than 66.37% of its industry peers.
  • In the last couple of years the Gross Margin of PGNY has grown nicely.

How do we evaluate the setup for NASDAQ:PGNY?

ChartMill also assign a Setup Rating to every stock. With this score it is determined to what extend the stock has been trading in a range in the recent days and weeks. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. NASDAQ:PGNY scores a 8 out of 10:

PGNY has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately and the volatility has been reduced. There is very little resistance above the current price. We notice that large players showed an interest for PGNY in the last couple of days, which is a good sign.

Our Strong Growth screener lists more Strong Growth stocks and is updated daily.

For an up to date full fundamental analysis you can check the fundamental report of PGNY

Our latest full technical report of PGNY contains the most current technical analsysis.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.

Back

PROGYNY INC

NASDAQ:PGNY (4/18/2024, 7:13:59 PM)

Premarket: 31.77 -0.11 (-0.35%)

31.88

-0.87 (-2.66%)

PGNY News

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

News Image15 days ago - ProgynyProgyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of...

News Imagea month ago - ProgynyProgyny, Inc. to Present at KeyBanc Life Sciences & MedTech Investor Forum

NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Imagea month ago - InvestorPlaceThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

News Imagea month ago - BusinessInsiderThe 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Wagering on mid-cap stocks can potentially unlock investment treasures typicall...

News Imagea month ago - ProgynyProgyny, Inc. to Present at Barclays 26th Annual Global Healthcare Conference

NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Seeking AlphaProgyny announces $100M share repurchase program (NASDAQ:PGNY)

Progyny (PGNY) approves $100 million share repurchase program funded by available cash balances.

News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program
News Image2 months ago - ProgynyProgyny, Inc. Announces Share Repurchase Program

NEW YORK, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits...

News Image2 months ago - Market News VideoWednesday Sector Laggards: Hospital & Medical Practitioners, Oil & Gas Refining & Marketing Stocks
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results
News Image2 months ago - ProgynyProgyny, Inc. Announces Fourth Quarter 2023 Results

Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% GrowthAchieves 49% Growth in Adjusted EBITDA to Record $187.1 MillionIssues Financial Guidance for 2024, Crossing the $1.3 Billion Milestone at Midpoint

PGNY Links
Follow us for more